Laboratorio Reig Jofre SA (RJF)
BME
2.62
+0.01 (+0.38%)
Closed
Oct 7, 2026
Day's Range
2.622.68
52 wk Range
2.323.21
Financial Statements - RJF - Laboratorio Reig Jofre SA
Revenue
331.09M▼ 2.3%
Net Income
4.99M▼ 52.2%Net Margin 1.5%
EBITDA
36.03M▼ 4.3%
Free Cash Flow
-16.79M▼ 259.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 331.09M | 338.89M | 316.08M | 271.15M | 236.23M | 230.07M |
| Cost of Goods | 135.25M | 143.21M | 137.07M | 113.80M | 91.25M | 89.68M |
| Gross Profit | 195.84M | 195.68M | 179.01M | 157.34M | 144.97M | 140.39M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 6.80M | 15.07M | 12.43M | 9.20M | 9.36M | 9.85M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 6.32M | 11.82M | 10.49M | 8.76M | 5.79M | 6.42M |
| Income Tax | 1.32M | 1.35M | 1.09M | 658K | 713K | 760K |
| Net Income | 4.99M | 10.46M | 9.39M | 8.10M | 5.08M | 5.66M |
| EPS Basic | 0.06 | 0.130744 | 0.12 | 0.1 | 0.07 | 0.07 |
| EPS Diluted | 0.06 | 0.130744 | 0.12 | 0.1 | 0.07 | 0.07 |
| Basic Shares Outstanding | 81.38M | 80.05M | 78.80M | 78.88M | 77.85M | 76.98M |
| Diluted Shares Outstanding | 81.38M | 80.05M | 78.80M | 78.88M | 77.85M | 76.98M |
| Ebit | 7.68M | 12.82M | 11.24M | 9.45M | 6.47M | 7.10M |
| Ebitda | 36.03M | 37.65M | 36.20M | 31.71M | 26.95M | 26.71M |
| Net Income Continuous Operations | 6.32M | 11.82M | 10.49M | 8.76M | 5.79M | 6.42M |
| Minority Interests | 23K | -85K | 10K | 1K | 12K | 6K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
